DePuy Orthopaedic Recall Not Soon Enough for Some Doctors
DePuy Orthopaedic Recall Not Soon Enough for Some Doctors
Following the recall of certain DePuy hip implant devices, some orthopedic surgeons expressed concern that a recall was not announced sooner. The doctors point to the high rate of revision surgery associated with DePuy hip implant devices as a reason why the DePuy recall should have been announced sooner. DePuy Orthopaedics, maker of the devices, previously announced they would stop making the implants involved in the DePuy recall because of slowing sales, but a high failure rate resulted in the DePuy Orthopaedics recall.
According to an article in The New York Times (08/27/10), some orthopedic experts were concerned that the DePuy recall was not announced sooner. Information from DePuy Orthopaedics indicates that around 12 percent of patients who received a DePuy hip implant required revision surgery within five years of receiving the implant.
Although a statement from DePuy Orthopaedics indicated that previous research showed a revision rate that was comparable with other, similar devices from other companies, some doctors say they noticed a high failure rate in the DePuy hip replacement devices.
In an interview with The New York Times, Dr. Joshua J. Jacobs said, "Most major medical centers have seen issues with this device. This does not come as a surprise." Furthermore, some doctors suggested that a design flaw made the DePuy hip replacement difficult to implant. Specifically, they point to the shallow design of the ASR cup, which may have made the device more difficult to implant.
Included in the recall are the ASR XL Acetabular System and the ASR Hip Resurfacing System. Approximately 93,000 units of the devices are affected by the DePuy recall. The DePuy hip implant devices are known as metal-on-metal implants and can cause large amounts of metallic shavings to be released into the patient's tissue. Those shavings can damage the surrounding muscles and soft tissue, causing the hip implant to fail.
In March 2010, DePuy Orthopaedics sent a letter to doctors alerting them to the high failure rate.
An article in The New York Times (03/10/10) notes that since January 2008, the FDA has received approximately 300 complaints concerning the DePuy ASR systems. The actual failure rate could be higher, however, because many problems with medical devices go unreported.
Lawsuits have been filed against DePuy Orthopaedics and its parent company, Johnson & Johnson, regarding the DePuy hip implants. The lawsuits allege that the DePuy implants had a design flaw, resulting in a high failure rate and resulting in revision surgeries. They further allege that DePuy knew about problems with the hip implants but failed to adequately warn doctors or patients about those risks. Buy Best Health Insurance Plans In Dubai Exactly what would be the most beneficial doctor to choose for those who have whiplash!? Brief-Term Health Insurance - The Benefits Pennsylvania residents could lose health insurance Health Insurance Reform Weekly Easy To Insure ME Alleviate Inflammation By using a Balanced Pregnancy Diet Health Insurance Providers Also Provide Short Term Solutions Blue Cross Blue Shield of Florida – Picking Your Individual Health Insurance Blue Cross Blue Shield of Florida – Individual Health Insurance Plans Tennessee Health Insurance And Healthcare Reform Lexington Ky Massage Alleviates Stress & Pain Differences In Dissertations Of Masters And Doctorate Students Anthem Health Insurance Enrollment Form - The Right Way To Find It